Reply to: "Age-Adjusted Serum Neurofilament Predicts Cognitive Decline in Parkinson's Disease (MARK-PD)"

Mov Disord. 2022 Feb;37(2):436-437. doi: 10.1002/mds.28920.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cognitive Dysfunction* / blood
  • Cognitive Dysfunction* / etiology
  • Humans
  • Intermediate Filaments
  • Neurofilament Proteins
  • Parkinson Disease* / blood
  • Parkinson Disease* / complications

Substances

  • Neurofilament Proteins